Sleep and COMT polymorphism in ADHD children: Preliminary actigraphic data

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 45, Issue 8, 2006, Pages 982-989

  Gruber, Reut ^a   Grizenko, Natalie ^a   Schwartz, George ^a   Ben Amor, Leila ^b   Gauthier, Julie ^a   De Guzman, Rosherrie ^a   Joober, Ridha ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Attention deficit hyperactivity disorder; Catechol O methyltransferase; COMT; Genotype; Sleep

Indexed keywords

CATECHOL METHYLTRANSFERASE; METHIONINE; METHYLPHENIDATE; VALINE;

ACTIMETRY; ALLELE; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENZYME POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP; SLEEP DISORDER;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CATECHOL O-METHYLTRANSFERASE; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CROSS-OVER STUDIES; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE-BLIND METHOD; FEMALE; GENOTYPE; HUMANS; MALE; METHYLPHENIDATE; POLYMORPHISM, GENETIC; POLYSOMNOGRAPHY; SLEEP;

EID: 33745787795     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.chi.0000220848.48650.10     Document Type: Article

References (51)

1. American Psychiatric Association (1994), Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). Washington, DC: American Psychiatric Association
2. Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W, Pollak CP (2003), The role of actigraphy in the study of sleep and circadian rhythms. Sleep 26:342-392
3. Archbold K, Giordani B, Ruzicka D, Chervin R (2004), Cognitive executive dysfunction in children with mild sleep-disordered breathing. Biol Res Nurs 5:168-176
4. Bilder RM, Volavka J, Lachman HM, Grace AA (2004), The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 29:1943-1961
5. 158 Met genotype on attentional control. J Neurosci 18:5038-5045
6. Bobb AJ, Castellanos FX, Addington AM, Rapoport JL (2005), Molecular genetic studies of ADHD. Am J Med Genet B Neuropsychiatr Genet 132:109-125
7. Chervin R, Dillon J, Bassetti C, Ganoczy D, Pituch K (1997), Symptoms of sleep disorders, inattention, and hyperactivity in children. Sleep 20:1185-1192
8. Cohen-Zion M, Ancoli-Israel S (2004), Sleep in children with attention-deficit hyperactivity disorder (ADHD): a review of naturalistic and stimulant intervention studies. Sleep Med Rev 8:379-402
9. Corkum P, Moldofsky H, Hogg-Johnson S, Humphries T, Tannock R (1999), Sleep problems in children with attention-deficit/hyperactivity disorder: impact of subtype, comorbidity, and stimulant medication. J Am Acad Child Adolesc Psychiatry 38:1285-1293
10. Dauvilliers Y, Maret S, Tafti M (2005), Genetics of normal and pathological sleep in humans. Sleep Med Rev 9:91-100
11. Dauvilliers Y, Neidhart E, Lecendreux M, Billiard M, Tafti M (2001), MAO-A and COMT polymorphisms and gene effects in narcolepsy. Mol Psychiatry 6:367-372
12. Durmer JS, Dinges DF (2005), Neurocognitive consequences of sleep deprivation. Semin Neurol 25:117-129
13. 108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 98:6917-6922
14. Eisensehr I, Linke R, Tatsch K, et al (2003), Alteration of the striatal dopaminergic system in human narcolepsy. Neurology 60:1817-1819
15. Faraone SV, Perlis RH, Doyle AE, et al (2005), Molecular genetics of attention-deficit/hyperactiviry disorder. Biol Psychiatry 57:1313-1323
16. Frauscher B, Hogl B, Maret S, et al (2004), Association of daytime sleepiness with COMT polymorphism in patients with Parkinson disease: a pilot study. Sleep 27:733-736
17. Gadow KD, Sverd J, Sprafkin J, Nolan EE, Ezor SN (1995), Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder. Arch Gen Psychiatry 52:444-455
18. Gottesmann C (2002), The neurochemistry of waking and sleeping mental activity: the disinhibition-dopamine hypothesis. Psychiatry Clin Neurosci 56:345-354
19. Grossman MH, Emanuel BS, Budarf ML (1992), Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1-q11.2. Genomics 12:822-825
20. Gruber R, Sadeh A (2004), Sleep and neurobehavioral functioning in children with ADHD. Sleep 27:267-273
21. Gruber R, Sadeh A, Raviv A (2000), Instability of sleep patterns in children with ADHD. J Am Acad Child Adolesc Psychiatry 39:495-501
22. Jones BE (2003), Arousal systems. Front Biosci 1:438-451
23. Joober R, Gauthier J, Lal S, et al (2002), Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. Arch Gen Psychiatry 59:662-663
24. Kimura K, Tsai CW (1984), Ultradian rhythm of growth hormone secretion and sleep in the adult male rat. J Physiol (Lond) 353:305-3315
25. Kirov R, Kinkelbur J, Heipke S, et al (2004), Is there a specific polysomnographic sleep pattern in children with attention deficit/hyperactivity disorder? J Sleep Res 13:87-93
26. Konofal E, Lecendreux M, Bouvard MP, Mouren-Simeoni MC (2001), High levels of nocturnal activity in children with attention-deficit hyperactivity disorder: a video analysis. Psychiatry Clin Neurosci 55:97-103
27. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM (1996), Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6:243-250
28. Lavie P (2005), Genetics wakes up for human sleep. Sleep Med Rev 9:87-89
29. Lundstrom K, Tenhunen J, Tilgmann C, Karhunen T, Panula P, Ulmanen I (1995), Cloning, expression and structure of catechol-O-methyltransferase. Biochim Biophys Acta 1251:1-10
30. Maguire-Zeiss KA, Short DW, Federoff HJ (2005), Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease. Brain Res Mol Brain Res 134:18-23
31. Malhotra AK, Kestler LJ, Mazzanti C, Bates JA, Goldberg T, Goldman D (2002), Functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry 159:652-654
32. MTA Cooperative Group (2004), National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics 113:762-769
33. National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention (2001), Attention-Deficit/Hyperactivity Disorder - A Public Health Perspective. Atlanta: NCBDDD
34. O'Brien LM, Holbrook CR, Mervis CB, et al (2003a), Sleep and neurobehavioral characteristics of 5- to 7-year-old children with parentally reported symptoms of attention-deficit/hyperactivity disorder. 111:554-563
35. O'Brien LM, Ivanenko A, Crabtree VM, et al (2003b), The effect of stimulants on sleep characteristics in children with attention deficit/hyperactivity disorder. Sleep Med 4:309-316
36. Owens J (2005), The ADHD and sleep conundrum: a review. J Dev Behav Pediatr 26:312-322
37. Picchietti DL, Underwood DJ, Farris WA (1999), Further studies on periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder. Mov Disord 14:1000-1007
38. Pliszka SR (2005), The neuropsychopharmacology of attention-deficit/ hyperactivity disorder. Biol Psychiatry 57:1385-1390
39. Rissling I, Geller F, Bandmann O, et al (2004), Dopamine receptor gene polymorphisms in Parkinson's disease patients reporting "sleep attacks". Mov Disord 19:1279-1284
40. Rosa A, Peralta V, Cuesta MJ, et al (2004), New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis. Am J Psychiatry 161:1110-1112
41. Rye DB (2004), The two faces of Eve: dopamine's modulation of wakefulness and sleep. Neurology 26:S2-S7
42. Rye DB, Jankovic J (2002), Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD. Neurology 58:341-346
43. Sadeh A, Acebo C (2002), The role of actigraphy in sleep medicine. Sleep Med Rev 6:113-124
44. Sadeh A, Gruber R, Raviv A (2002), Sleep, neurobehavioral functioning and behavior problems in school-age children. Child Dev 73:405-417
45. Sassin JF, Parker DC, Mace JW (1969), Human growth hormone release: relation to slow-wave sleep and sleep-waking cycles. Science 165:513-515
46. Shaffer D, Fisher P, Lucas CP, Dulcan MK, Schwab-Stone ME (2000), NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses. J Am Acad Child Adolesc Psychiatry 39:28-38
47. Silber MH, Rye DB (2001), Solving the mysteries of narcolepsy: the hypocretin story. Neurology 56:1616-1618
48. Sprafkin J, Gadow KD (1996), Double-blind versus open evaluations of stimulant drug response in children with attention-deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 6:215-228
49. Takahashi Y, Ebihara S, Nakamura Y (1981), A model of human sleep-related growth hormone secretion in dogs: effects of 3, 6, and 12 hours of forced wakefulness on plasma growth hormone, cortisol, and sleep stages. Endocrinology 109:262-272
50. Tolosa E, Barone P, Rye DB (2004), Parkinson's disease and sleep. Neurology 63:S1
51. Wechsler D (1991), Manual for the Wechsler Intelligence Scale for Children-Third Edition. San Antonio, TX: The Psychological Corporation